← Back to ARWR

Arrowhead Pharmaceuticals Inc. financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 07/05/2026Dec 2025Filed 05/02/2026Jun 2025Filed 04/08/2026Mar 2025Filed 07/05/2026Dec 2024Filed 05/02/2026Jun 2024Filed 07/08/2025Mar 2024Filed 12/05/2025
$75$74$264$28$543$2.5$0$0
−$194−$133$31−$175$370−$173−$171−$125
−$1.36−$0.93$0.22−$1.26$2.75−$1.39−$1.38−$1.02
143142141139134125124123

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.